TrialEuropean radiology2017

MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial.

Francesco Giganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.